Search results
10 Best ETFs To Buy and Hold for Long-Term Growth
GoBankingRates via AOL· 3 days agoIf you're a long-term investor looking to diversify your growth portfolio, there are a number of exchange-traded funds that can help you reach your...
Why Regeneron Stock Finally Joined The 1,000-Club
Investor's Business Daily· 2 days agoEnthusiasm is growing for a looming approval in COPD treatment.
Most CEOs are defeating attempts to vote down their pay. Can Tesla's Elon Musk do the same?
AOL· 5 days agoThe question now is whether Tesla (TSLA) CEO Elon Musk can do the same. Just two companies out of 340 that held shareholder votes on CEO pay as of June 6 had their executive pay packages rejected ...
Find Out Who Owns Jeep in 2024 | The Motley Fool
The Motley Fool· 2 days agoThe automaker's roots date back to World War II, and the company's vehicles have been serving the needs of American drivers (on and off-road) for...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks· 5 days agoFree Report) announced that the FDA has approved the expanded use of its respiratory syncytial virus (RSV) vaccine, Arexvy for adults aged 50-59 who are at increased risk of RSV disease. Arexvy ...
A Deep Dive into the New Amplify Weight Loss Drug & Treatment ETF (THNR) | Investing.com Canada
Investing.com· 4 days agoETF investors are quick to jump from one trend to another, and the latest focus is on companies...
Ongoing Efforts to Expand Kidney Donor Pool Seem Mostly Safe
Medscape· 3 days agoLiving donors had a similar risk for hypertension and albuminuria after donation as nondonors, and...
Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma
MedPage Today· 5 days agoImmunotherapy may have been given too late, researchers suggested
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with...
KSAN - KLST San Angelo· 4 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the ...